surmount-1 tirzepatide weight loss percent 72 weeks for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled trial Tirzepatide proves to be more
Pay in 4 interest-free payments of $6.98 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Nov 9 - Nov 14



00377-2/asset/5849e908-c26a-472e-b460-1c99904b95c5/main.assets/gr2.jpg)


















